SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
18
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Scynexis Inc market cap is $23.69M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Scynexis Inc 52 week high is $9.12 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Scynexis Inc 52 week low is $2.30 as of November 21, 2026.
Scynexis Inc stock price today is $2.38.
Scynexis Inc stock price yesterday was $2.61.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Scynexis Inc's P/E ratio is -2.02.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Scynexis Inc P/B ratio is 0.4012.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Scynexis Inc 50-day moving average is $3.98.